News – Page 4 – Alligator Bioscience

2021-09-02

Positive Results from the Scandion Oncology and Alligator Bioscience Collaboration Further Supports Efficacy of Mitazalimab in Combination Therapy

Lund, Sweden, September 2, 2021 – Alligator Bioscience AB (Nasdaq Stockholm: ATORX) and Scandion Oncology A/S (Nasdaq Stockholm: SCOL), toda ...

2021-08-18

Regulatory

Alligator Bioscience (Nasdaq Stockholm: ATORX) announced today that the company has entered into a research collaboration and license agreem ...

2021-08-16

Lund, Sweden, August 16, 2021 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that Julie Silber has joined the company as t ...

2021-07-13

Regulatory

Positive Phase I data for ATOR-1017 ”As new CEO of Alligator Bioscience, after just around a month, let me say that my high expectations on ...

2021-06-30

Lund, Sweden, June 30, 2021 – Alligator Bioscience (Nasdaq Stockholm: ATORX) and Scandion Oncology (Nasdaq Stockholm: SCOL) today announces ...

2021-06-07

Lund, Sweden, June 7, 2021 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announces that the scientific journal Expert Opinion on Bi ...

2021-06-04

Regulatory